1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylic acid

Catalog No.: 
ACSEVV539
CAS No.: 
2091154-19-5
Molecular Formula: 
C23H22N4O4
Molecular Weight: 
418.45
1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$460.00InquiryInquiry
100mg95%$680.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylic acid
IUPAC Name1-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylic acid
MDL No.MFCD31559970
Molecular FormulaC23H22N4O4
Molecular Weight418.45
SMILESO=C(C1=CN(C2CCN(C(OCC3C4=C(C5=C3C=CC=C5)C=CC=C4)=O)CC2)N=N1)O
InChI KeyWBTDIGXOUCZPBM-UHFFFAOYSA-N
Synonym1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylic acid;1-Piperidinecarboxylic acid, 4-(4-carboxy-1H-1,2,3-triazol-1-yl)-, 1-(9H-fluoren-9-ylmethyl) ester
CAS No.2091154-19-5

Synthetic Route by SureRoute

1. ACSEVV539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDCGV413 route compound structure diagram
    ACDCGV413920-38-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSEVV539 route product structure diagram
    ACSEVV5392091154-19-5
Inquiry

2. ACSEVV539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSEVV539 route product structure diagram
    ACSEVV5392091154-19-5
Inquiry

3. ACSEVV539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSEVV539 route product structure diagram
    ACSEVV5392091154-19-5
Inquiry

Comments (0)